Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a Tertiary care hospital

M., Usman; G. N., Kakepoto; S. N., Adil; R., Sajid; S., Arain; M., Khurshid.

JPMA-Journal of Pakistan Medical Association. 2004; 54 (1): 17-20

in English | IMEMR | ID: emr-175582

ABSTRACT

Objective:

To evaluate the response of Imatinib mesylate in patients with myeloid leukemia in chronic, accelerated and blast phase

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: J. Pak. Med. Assoc. Year: 2004

MEDLINE

LILACS

LIS

Search on Google

Index: IMEMR (Eastern Mediterranean) Language: English Journal: J. Pak. Med. Assoc. Year: 2004